专利摘要:
6-Substituted 10 beta -alkynylestrene derivatives of formula (I): …<CHEM>… wherein… X is hydrogen, C1-C4 alkyl or halogen;… n is zero, 1 or 2;… Y is an oxo group or a methylene group;… the symbol @ indicates a single bond or a double bond;… R1 is halogen, azido or a group …<CHEM>… wherein each of R3 and R4 is, independently, hydrogen or C1-C4 alkyl, or R1 may be divalent and is a C1-C6 alkylidene group; and R2 is hydrogen or, when R1 is halogen, R2 may also be the same halogen as R1,… and the pharmaceutically acceptable salts thereof; are aromatase inhibitors and can be used, e.g., in the treatment of hormone-dependent tumors and prostatic hyperplasia.
公开号:SU1577701A3
申请号:SU864028669
申请日:1986-12-22
公开日:1990-07-07
发明作者:Фаустини Франко;Ди Салле Энрико;Вилла Витториа;Ломбарди Паоло
申请人:Фармиталиа Карло Эрба С.П.А. (Фирма);
IPC主号:
专利说明:

10- (2-propinyl) estr-4-en-3, 1 7
dione (comparative) 31
Aminogluttimid (comparative1750
10 B- (2-Propinyl-6-methylene-4-ene-3, 17-dione19
(FCE 24716)
10 ft - (2-Propinyl) -6-methylenestra-1, 4-diene-3,17-dione17
权利要求:
Claims (1)
[1]
Claim
10 p-alkynylesthetic general formula
The method of obtaining reno derivatives symbol. G, --- single or double carbon-carbon bond;
R / is an alkylidene group C 4 ~ C 3 , distinct a. that the compound of the general formula
40 where η has the indicated value, is reacted with a Vilsmeier reagent carrying the remainder. R ^, and a compound of formula (I) is obtained, where η has the indicated value, d5 is a single bond, and, if necessary, the compound of formula (I) is subjected to dehydrogenation with obtaining the corresponding compound, where the carbon-carbon double bond.
Compound | 1 C 50 , nm 10- (2-Propynyl) estr-4-en-Z, 17 dion (comparative) 31 ‘ Aminogluttimide (comparative 1750 10 β- (2-Propinyl) -6 ~ methylene- estra-4-en-3,1 7-dione 19 (FCE 24716) 10 p - (2-propynyl) -6-methylene- estra-1, 4-diene-3,1 7-dion . 17
类似技术:
公开号 | 公开日 | 专利标题
SU1577701A3|1990-07-07|Method of obtaining 10 beta-alkynilestrene derivatives
BR9814340A|2000-10-03|Indole derivatives as factor xa inhibitors
MD1233B1|1999-05-31|Erythromycin derivatives, process for their preparation and pharmaceutical composition on base thereof
BR9907788A|2001-10-30|Paraglycocorticoid selective anti-inflammatory agents
Shikita et al.1965|20α-Hydroxysteroid dehydrogenase of testes
IE44473L|1977-06-12|6,9,21-trihalo pregnanes
RU95114439A|1997-06-10|Derivatives of triazolebensazepine having antiallergic activity, method for their production, intermediates for their production, pharmaceutical composition on their base, method for its production
SU1537141A3|1990-01-15|Method of producing 6-methylene-1,2beta-methyleneandrost-4-ene-3,17-dion
Neil et al.1971|Biochemical and pharmacologic studies with 1-β-d-arabinofuranosylcytosine 5′-adamantoate |, a depot form of cytarabine
Kano et al.1976|Direct action of melatonin of testosterone and cyclic GMP production using rat testis tissue invitro
Jerussi et al.1965|The mechanism of the bacterial C-1, 2 dehydrogenation of steroids. III. Kinetics and isotope effects
Shikita et al.1967|Further studies on 20α-hydroxysteroid dehydrogenase of rat testes
Goodwin et al.1996|Growth hormone-responsive DT-diaphorase-mediated bioreduction of tetrazolium salts
BG103271A|2000-05-31|Derivatives of n-| piperidine-1-ethaneamines, method for their preparation and application as therapeutical means
Hiroshi et al.1971|Regulation of testosterone biosynthesis in rat testes by 7α-hydroxylated C19-steroids
AR004727A1|1999-03-10|THE USE OF A COMPOUND FOR THE TRANSFECTION OF CELLS AND A COMPOSITION
Burrow1969|A steroid inhibitory effect on adrenal mitochondria
Koritz1962|Inhibition of corticoid production in rat-adrenal homogenates by diphosphopyridine nucleotide and its reversal by ascorbate and other substances
Pike et al.1964|Synthesis and biological properties of some unique cytotoxic steroids
BERMEK et al.1970|Human Protein Synthesis, V. The Effect of Antibiotics on an Optimized Polyphenylalanine Synthesizing Cell-free System from Human Lymphatic Tissue
GB1530837A|1978-11-01|3beta-|-steroids and their use in the production of steroids from sarsaponin
Casanova et al.1953|593. Steroids. Part V. Partial synthesis of 9: 11-anhydrocorticosterone acetate [21-acetoxypregna-4: 9 |-diene-3: 20-dione]
Bartova et al.1971|Steroid-mediated stimulation of aerobic glycolysis by intact mouse adrenal glands in vitro
Wenkert et al.1957|THE STEREOCHEMICAL INTERRELATIONSHIP OF THE YOHIMBINE-TYPE ALKALOIDS1
Macdonald et al.1975|Lyophilized 7 α-hydroxysteroid dehydrogenase: a stable enzyme preparation for routine bile acid analysis
同族专利:
公开号 | 公开日
EP0227472A1|1987-07-01|
FI83522C|1991-07-25|
IL81008D0|1987-03-31|
PT84013A|1987-01-01|
GB8531747D0|1986-02-05|
GR3000222T3|1991-03-15|
ZA869459B|1987-08-26|
EP0227472B1|1989-10-18|
AT47398T|1989-11-15|
FI865259A|1987-06-25|
PT84013B|1989-07-31|
JPS62158300A|1987-07-14|
AU599942B2|1990-08-02|
DK624586D0|1986-12-22|
FI865259A0|1986-12-22|
HUT44574A|1988-03-28|
FI83522B|1991-04-15|
ES2011618B3|1990-02-01|
NZ218714A|1990-02-26|
DE3666438D1|1989-11-23|
DK624586A|1987-06-25|
US4808578A|1989-02-28|
IL81008A|1991-06-10|
HU197919B|1989-06-28|
CA1310957C|1992-12-01|
KR870006082A|1987-07-09|
AU6666186A|1987-06-25|
引用文献:
公开号 | 申请日 | 公开日 | 申请人 | 专利标题

US2744120A|1953-01-14|1956-05-01|Olin Mathieson|1-dehydrotestololactone|
GB1042291A|1961-11-08|1966-09-14|Organon Labor Ltd|í¸-6ª‡-amino steroids and the preparation thereof|
US4322416A|1980-06-27|1982-03-30|Merrell Dow Pharmaceuticals Inc.|10-Alkynyl steroids|
US4289762A|1980-06-27|1981-09-15|Merrell Dow Pharmaceuticals Inc.|10- steroids as irreversible aromatase inhibitors|
DE3121153C2|1981-05-22|1991-06-20|Schering Ag|
US4446071A|1982-09-09|1984-05-01|E. R. Squibb & Sons, Inc.|Intermediates useful in the preparation of 17,17-bis androstenes|
US4546098A|1984-04-13|1985-10-08|The Rockefeller University|Estrogen synthesis inhibitors|US4534722A|1984-04-16|1985-08-13|Gold Bond Ice Cream, Inc.|Forming and conveying of baked confection shells|
US4882322A|1988-10-27|1989-11-21|Merrell Dow Pharmaceuticals Inc.|3β,17β-hydroxy-substituted steroids and related steroidal compounds|
CA2038985C|1990-04-02|2002-10-15|Gestion De La Sante Marion Merrell Dow Canada Inc.-Marion Merrell Dow Ca Nada Health Management Inc.|Haloethyl-substituted steroidal enzyme inhibitors|
CH683151A5|1991-04-24|1994-01-31|Ciba Geigy Ag|Contraception in female primates without affecting the menstrual cycle.|
US6407082B1|1996-09-13|2002-06-18|New Life Pharmaceuticals Inc.|Prevention of ovarian cancer by administration of a vitamin D compound|
US6034074A|1996-09-13|2000-03-07|New Life Pharmaceuticals Inc.|Prevention of ovarian cancer by administration of a Vitamin D compound|
US6028064A|1996-09-13|2000-02-22|New Life Pharmaceuticals Inc.|Prevention of ovarian cancer by administration of progestin products|
US6511970B1|1996-09-13|2003-01-28|New Life Pharmaceuticals Inc.|Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium|
US6765002B2|2000-03-21|2004-07-20|Gustavo Rodriguez|Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium|
US20010044431A1|2000-03-21|2001-11-22|Rodriguez Gustavo C.|Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium|
EP2556082B1|2010-04-08|2017-02-22|Emory University|Substituted androst-4-ene diones|
法律状态:
优先权:
申请号 | 申请日 | 专利标题
GB858531747A|GB8531747D0|1985-12-24|1985-12-24|10beta-alkynylestrene derivatives|
[返回顶部]